Developed as a collateral to the Blood and Beyond Report, this Briefing overviews the impact of the COVID-19 pandemic in the field and offers policy-level recommendations, reiterating the need to rethink blood use in Europe. It is a collaborative effort of experts from the fields of haematology and blood management, nursing and patient advocacy.
The following experts contributed to this paper:

  • Erik Aerts, President, Haematology Nurses and Healthcare Professionals Group, Winterthur, Switzerland
  • Dr Androulla Eleftheriou, Executive Director, Thalassaemia International Federation, Strovolos, Cyprus
  • Prof. Dr Antonis Kattamis, Professor of Paediatric Hematology–Oncology, University of Athens and Head, Division of Hematology-Oncology, First Department of Pediatrics, National and Kapodistrian University of Athens, “Aghia Sofia” Children’s Hospital, Athens, Greece
  • Daniel Gallego, President, European Kidney Patients Federation, Spain
  • Dr Axel Hofmann, Visiting Professor, Institute of Anaesthesiology, University Hospital Zürich, Zürich, Switzerland, and Adjunct Associate Professor, School of Medicine, University of Western Australia, Australia
  • Dr Esther Natalie Oliva, Department of Haematology, Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli di Reggio Calabria; Reggio Calabria, Italy, and Board Member, European Haematology Association Scientific Working Group on Quality of Life
  • Ber Oomen, Member, Advisory Committee, European Specialists Nurses Organisation (ESNO); and Director, Foundation of Nurse Specialists Europe, Arnhem, Netherlands

We need an inspired action plan for responsible blood use and sustainable, pandemic-proof and patient-centered blood service.

Prof. Antonis Kattamis

Through a better blood transfusion policy, training for healthcare professionals and where possible offering alternative treatment options to patients with anemia and chronic diseases, the quality of life for these patients will increase.

Eric Aerts

Blood and Beyond is raising awareness about the challenges surrounding transfusions, notably amid the COVID-19 pandemic. Measures to overcome these challenges are crucial, to encourage blood donations, appropriate blood use, while taking full precautions to minimize risks resulting from COVID-19. The Blood and Beyond initiative is addressing these new challenges, working together with all relevant stakeholders.

Daniel Gallego